| 缩写名/全名 |
MOL THER-METH CLIN D
Molecular Therapy-Methods & Clinical Development |
||||||||||||||||||||||||
| ISSN号 | 2329-0501 | ||||||||||||||||||||||||
| 研究方向 | - | ||||||||||||||||||||||||
| 影响因子 | 2015:0, 2016:2.61, 2017:3.681, 2018:4.875, 2019:4.533, | ||||||||||||||||||||||||
| 出版国家 | |||||||||||||||||||||||||
| 出版周期 | |||||||||||||||||||||||||
| 年文章数 | 135 | ||||||||||||||||||||||||
| 出版年份 | 0 | ||||||||||||||||||||||||
| 是否OA | Yes | ||||||||||||||||||||||||
| 审稿周期(仅供参考) | |||||||||||||||||||||||||
| 录用比例 | |||||||||||||||||||||||||
| 投稿链接 | https://mtm.msubmit.net/cgi-bin/main.plex | ||||||||||||||||||||||||
| 投稿官网 | https://www.cell.com/molecular-therapy-family/methods/latest-content | ||||||||||||||||||||||||
| h-index | 20 | ||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2329-0501%5BISSN%5D | ||||||||||||||||||||||||
| 中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
| 中科院SCI期刊分区 ( 2020年新版本) |
|
| 中国学者近期发表的论文 | |
| 1. | Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research Author: Liting You, Mengqian Li, Ruizhan Tong, Yuncong Liu, Jianxin Xue, You Lu Journal: Molecular Therapy-Methods & Clinical Development, 2019, Vol., , DOI:10.1016/j.omtm.2019.02.008 DOI |
| 2. | Rational Design of Gene Therapy Vectors Author: Dao Pan, Hildegard Büning, Chen Ling Journal: Molecular Therapy-Methods & Clinical Development, 2019, Vol.12, 246-247, DOI:10.1016/j.omtm.2019.01.009 DOI |
| 3. | MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7 Author: Xufeng Luo, Dongmei Zhang, Jun Xie, Qin Su, Xing He, Ruipu Bai, Guangping Gao, Weiqing Pan Journal: Molecular Therapy-Methods & Clinical Development, 2018, Vol.11, 73-82, DOI:10.1016/j.omtm.2018.10.002 DOI |
| 4. | P-FN12, an H4R-Based Epitope Vaccine Screened by Phage Display, Regulates the Th1/Th2 Balance in Rat Allergic Rhinitis Author: Yuqian Wang, Jichao Sha, Heng Wang, Lifeng An, Tie Liu, Lin Li Journal: Molecular Therapy-Methods & Clinical Development, 2018, Vol.11, 83-91, DOI:10.1016/j.omtm.2018.09.004 DOI |
| 5. | A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors Author: Qizhao Wang, Zhongren Wu, Junping Zhang, Jenni Firrman, Hongying Wei, Zhengjing Zhuang, LinShu Liu, Linqing Miao, Yang Hu, Dong Li, Yong Diao, Weidong Xiao Journal: Molecular Therapy-Methods & Clinical Development, 2017, Vol.7, 146-156, DOI:10.1016/j.omtm.2017.11.002 DOI |
| 6. | Production and clinical development of nanoparticles for gene delivery Author: Jie Chen, Zhaopei Guo, Huayu Tian, Xuesi Chen Journal: Molecular Therapy-Methods & Clinical Development, 2016, Vol.3, 16023, DOI:10.1038/mtm.2016.23 DOI |
| 7. | Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors Author: Qizhao Wang, Biao Dong, Katie A. Pokiniewski, Jenni Firrman, Zhongren Wu, Mario P.S. Chin, Xiongwen Chen, LinShu Liu, Ruian Xu, Yong Diao, Weidong Xiao Journal: Molecular Therapy-Methods & Clinical Development, 2017, Vol.4, 149-158, DOI:10.1016/j.omtm.2016.12.004 DOI |
| 8. | Increasing the minicircle DNA purity using an enhanced triplex DNA technology to eliminate DNA contaminants Author: Xiaohu H Hou, Xiaoyan Y Guo, Yusheng Chen, Cheng-Yi He, Zhi-Ying Chen Journal: Molecular Therapy-Methods & Clinical Development, 2015, Vol.2, 14062, DOI:10.1038/mtm.2014.62 DOI |
| 9. | A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9 Author: Ming Yuan, Xuefei Gao, Louisa S Chard, Zarah Ali, Jahangir Ahmed, Yunqing Li, Pentao Liu, Nick R Lemoine, Yaohe Wang Journal: Molecular Therapy-Methods & Clinical Development, 2015, Vol.2, 15035, DOI:10.1038/mtm.2015.35 DOI |
|
|